EMAIL THIS PAGE TO A FRIEND

Journal of animal science

Equine endometrial gene expression changes during and after maternal recognition of pregnancy.


PMID 26440005

Abstract

The mechanism for maternal recognition of pregnancy (MRP) in horses is unknown. To maintain a pregnancy, a mobile conceptus must be recognized by the uterus before d 14 postovulation (PO). This recognition prevents endometrial secretion of PGF2α on d14 through 16, which would otherwise initiate luteolysis. The objective of this study was to evaluate gene expression in the endometrium of pregnant and nonpregnant mares during and after MRP to identify possible genes involved during this time. Twelve normally cycling mares were used in a crossover design and randomly assigned to a specific collection day. Endometrial samples were collected from a pregnant and nonpregnant (nonmated) mare on cycle d 12, 14, 16, and 18 (n = 3/d) PO. Microarray analysis comparing the endometrial gene expression in pregnant and nonpregnant mares revealed no differences at d 12. Ten genes were identified to have consistently higher or lower expression levels in the endometrium from pregnant versus nonpregnant mares on d 14, 16, and 18 (P < 0.001). The expression of these 10 genes was further analyzed with real-time PCR. d 14, 16, and 18 gene expression patterns were consistent with the microarray analysis, but on d 12, 4 of the 10 were identified as differentially expressed. Endometrial samples were then collected on d 13 PO (n = 3) and processed for western blot and immunohistochemical analysis of 2 proteins due to their reproductive significance. SPLA2 and DKK1 antibody specificity were confirmed via western blot analysis but were not different in samples from pregnant and nonpregnant mares (P = 0.114 and P = 0.514, respectively) and cellular localization was examined by immunohistochemical analysis. This is the first study to describe gene expression and cellular localization in the endometrium at the time of MRP for these genes and suggests that the uterus does not prepare to support a pregnancy until d 14. The function of these genes may be critical in the process of MRP.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

A3553
Acrylamide, for electrophoresis, ≥99% (HPLC), powder
C3H5NO
A8887
Acrylamide, suitable for electrophoresis, ≥99%
C3H5NO
A9099
Acrylamide, for molecular biology, ≥99% (HPLC)
C3H5NO
A4058
Acrylamide solution, 40%, for electrophoresis, sterile-filtered
C3H5NO
A5508
Adenosine 5′-phosphosulfate sodium salt, ≥85%
C10H14N5O10PS
A3678
Ammonium persulfate, for molecular biology, for electrophoresis, ≥98%
H8N2O8S2
248614
Ammonium persulfate, ACS reagent, ≥98.0%
H8N2O8S2
215589
Ammonium persulfate, reagent grade, 98%
H8N2O8S2
A7460
Ammonium persulfate, BioXtra, ≥98.0%
H8N2O8S2
09913
Ammonium persulfate, BioUltra, for molecular biology, ≥98.0% (RT)
H8N2O8S2
31117
Ammonium persulfate, puriss. p.a., ACS reagent, reag. Ph. Eur., ≥98%
H8N2O8S2
S5770
Citrate Concentrated Solution, BioReagent, suitable for coagulation assays, 4 % (w/v)
C6H5Na3O7
83273
Citrate Concentrated Solution, BioUltra, for molecular biology, 1 M in H2O
C6H5Na3O7
T9281
N,N,N′,N′-Tetramethylethylenediamine, BioReagent, suitable for electrophoresis, ~99%
C6H16N2
T7024
N,N,N′,N′-Tetramethylethylenediamine, BioReagent, for molecular biology, ≥99% (GC)
C6H16N2
411019
N,N,N′,N′-Tetramethylethylenediamine, ≥99.5%, purified by redistillation
C6H16N2
T22500
N,N,N′,N′-Tetramethylethylenediamine, ReagentPlus®, 99%
C6H16N2
P7626
Phenylmethanesulfonyl fluoride, ≥98.5% (GC)
C7H7FO2S
78830
Phenylmethanesulfonyl fluoride, ≥99.0% (T)
C7H7FO2S
553468
Tris(tert-butoxy)silanol, 99.999%
C12H28O4Si
697281
Tris(tert-butoxy)silanol, packaged for use in deposition systems
C12H28O4Si